These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3189043

  • 1. The effect of danazol in the MRL/lpr mouse model of autoimmune disease.
    Connolly KM, Stecher VJ, Snyder BW, Bohnet E, Potts GO.
    Agents Actions; 1988 Aug; 25(1-2):164-70. PubMed ID: 3189043
    [Abstract] [Full Text] [Related]

  • 2. Danazol's failure to suppress autoimmunity in NZB/NZW F1 mice.
    Roubinian JR, Talal N, Greenspan JS, Goodman JR, Nussenzweig V.
    Arthritis Rheum; 1979 Dec; 22(12):1399-1402. PubMed ID: 316328
    [No Abstract] [Full Text] [Related]

  • 3. [Danazol and autoimmune thrombocytopenia in systemic lupus erythematosus].
    Selva A, Jordana R, Tolosa C, Ordi J.
    Med Clin (Barc); 1990 Apr 14; 94(14):557-8. PubMed ID: 2355774
    [No Abstract] [Full Text] [Related]

  • 4. The effect of OM-89 (Subreum) on the murine model of systemic lupus erythematosus MRL-lpr/lpr.
    Dhaher YY, Khamashta MA, Hartley B, Taub N, Farine JC, Hughes GR.
    Lupus; 1997 Apr 14; 6(5):436-40. PubMed ID: 9229361
    [Abstract] [Full Text] [Related]

  • 5. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).
    Katzav A, Kloog Y, Korczyn AD, Niv H, Karussis DM, Wang N, Rabinowitz R, Blank M, Shoenfeld Y, Chapman J.
    Clin Exp Immunol; 2001 Dec 14; 126(3):570-7. PubMed ID: 11737078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 10. Danazol for Evan's syndrome due to SLE.
    Aranegui P, Giner P, Lopez-Gomez M, el Amrani A, Jimenez-Alonso J.
    DICP; 1990 Jun 01; 24(6):641-2. PubMed ID: 2360344
    [No Abstract] [Full Text] [Related]

  • 11. Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement.
    Agnello V, Pariser K, Gell J, Gelfand J, Turksoy RN.
    J Rheumatol; 1983 Oct 01; 10(5):682-7. PubMed ID: 6606038
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An MRL/MpJ-lpr/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome.
    Fossati L, Takahashi S, Merino R, Iwamoto M, Aubry JP, Nose M, Spach C, Motta R, Izui S.
    Int Immunol; 1993 May 01; 5(5):525-32. PubMed ID: 8318455
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):270-9. PubMed ID: 16413531
    [Abstract] [Full Text] [Related]

  • 15. Nephritogenicity of the lprcg gene on the MRL background.
    Kimura M, Ogata Y, Shimada K, Wakabayashi T, Onoda H, Katagiri T, Matsuzawa A.
    Immunology; 1992 Jul 15; 76(3):498-504. PubMed ID: 1526655
    [Abstract] [Full Text] [Related]

  • 16. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ.
    J Immunol; 1998 Dec 15; 161(12):6999-7006. PubMed ID: 9862736
    [Abstract] [Full Text] [Related]

  • 17. Comparison of immunological effects of cholera toxin on autoimmune MRL/lpr and BXSB mice.
    Zhou NN, Nakai S, Oka M, Nagasawa H, Himeno K.
    Microbiol Immunol; 1992 Dec 15; 36(7):745-56. PubMed ID: 1406377
    [Abstract] [Full Text] [Related]

  • 18. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
    Hu N, Long H, Zhao M, Yin H, Lu Q.
    Scand J Rheumatol; 2009 Dec 15; 38(6):464-71. PubMed ID: 19922023
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E.
    Weimann BJ, Hermann D.
    Int J Vitam Nutr Res; 1999 Jul 15; 69(4):255-61. PubMed ID: 10450530
    [Abstract] [Full Text] [Related]

  • 20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.